Impact of imlifidase treatment on immunoglobulins in an HLA-hypersensitized lupus nephritis patient with anti-SSA/SSB antibodies after kidney transplantation: A case report
Bacterial recombinant cysteine protease Ides (imlifidase, Idefirix®, Hansa Biopharma) is used to prevent humoral transplant rejection in highly HLA-sensitized recipients, and to control IgG-mediated autoimmune diseases. We report the case of a 51 years old woman suffering from lupus nephritis with e...
Main Authors: | Jean Milhès, Olivier Marion, Benedicte Puissant, Caroline Carlé, Charlène Bouthemy, Arnaud Del Bello, Nassim Kamar, Yves Renaudineau, Nicolas Congy-Jolivet |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909023000369 |
Similar Items
-
Anti-SSA/SSB-negative primary Sjögren’s syndrome showing different clinical phenotypes: a retrospective study of 934 cases
by: Jiaqi Chen, et al.
Published: (2023-05-01) -
Neonatal lupus erythematosus – prevention is better
than cure
by: Agata Liszewska, et al.
Published: (2022-12-01) -
A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers
by: Sun T, et al.
Published: (2024-01-01) -
Autoimmune congenital heart block: a case report and review of the literature related to pathogenesis and pregnancy management
by: Ying Huang, et al.
Published: (2024-01-01) -
CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype
by: Ali M. Afzali, et al.
Published: (2023-02-01)